BCG Vaccination in COVID-19 Patients Admitted to the Emergency Department of a Low-Middle-Income Country: A Cross-Sectional Study.
Objective: To determine the severity and outcome of covid-19 patients who are vaccinated with BCG in our setup.Methodology: This cross-sectional study was conducted, from 20th February 2021 to 30th August 2021, at emergency department, Aga Khan University Hospital, Data of interest from 93 covid-19 cases was recorded on predesign proforma. A total of 93 covid 19 positive patients who were included in this study. Effect modifiers were controlled by stratification. Chi-square test was applied post stratification to calculate the expected value and p-value ≤0.05 was considered as significant.Results: The mean age of the patients was 47.36 years. Most patients were managed at special care unit for covid-19. We did not observe statistically significant association between BCG vaccinated patients (73.11%) and the age, gender, length of hospital stay, or patient disposition in this sample. (Observed p values were above 0.05).Conclusion: Most cases of covid-19 were BCG vaccinated but there were no statistically significant differences between vaccinated and non-vaccinated individuals in term of age, gender and length of hospital stay.Keywords: COVID 19, length of hospital stay and BCG vaccination.
Authors
- Nadeemullah Khan
- Akhtiar Ali
- Bariha Zehra Taqvi Syeda
- Ayesha Abbbasi
Institutions
- Jinnah Postgraduate Medical Center (PK)
- Aga Khan University Hospital Nairobi (KE)
- Dow University of Health Sciences (PK)
- South West London and St George's Mental Health NHS Trust (GB)
Publication Details
- Journal
- JMMC
- Published
- 2024-10-06
- DOI
- https://doi.org/10.62118/jmmc.v15i1.469
- Primary Topic
- Immune responses and vaccinations
- Type
- article
- Field-Weighted Citation Impact
- 0.00